MF
CLDI icon

Magnetar Financial’s Calidi Biotherapeutics CLDI Stock Holding History

Magnetar Financial’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-280
Closed -$6.31K – 554
2024
Q2 		$6.31K Sell
280
-246
-47% -$7.86K ﹤0.01% 494
2024
Q1 		$30.7K Hold
526
– – ﹤0.01% 350
2023
Q4 		$75.6K Buy
+526
New +$141K ﹤0.01% 345
2023
Q3 		– Sell
-526
Closed -$331K – 471
2023
Q2 		$331K Hold
526
– – 0.01% 388
2023
Q1 		$324K Hold
526
– – 0.01% 505
2022
Q4 		$15K Hold
526
– – ﹤0.01% 729
2022
Q3 		$79K Hold
526
– – ﹤0.01% 952
2022
Q2 		$0 Buy
+526
New +$626K ﹤0.01% 1693

Other funds holding CLDI

CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
CI
CPR Investments Rochester, Michigan $130M AUM 29.56% 1-Year Est. Return
RWI
Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
EWM
Evermay Wealth Management Arlington, Virginia $902M AUM 14.76% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Magnetar Financial's CLDI Position: Q3 2024 in Review

Magnetar Financial sold out of Calidi Biotherapeutics (CLDI) in Q3 2024, closing a stake of 280 shares — an estimated $6.31K sold.

Magnetar Financial first reported a position in CLDI in Q2 2022 and held it in 8 quarters. The position peaked at $331K in Q2 2023. 20 funds tracked by Wall St. Rank hold CLDI as of Q3 2024.

  • Magnetar Financial reported no remaining Calidi Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Magnetar Financial sold 280 Calidi Biotherapeutics shares in Q3 2024, an estimated $6.31K.
  • Magnetar Financial first reported a position in Calidi Biotherapeutics in Q2 2022 and held it in 8 quarters.
  • Magnetar Financial's Calidi Biotherapeutics position peaked at $331K in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2024.

Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.